Hantz Financial Services, Inc. Cv Sciences, Inc. Transaction History

Hantz Financial Services, Inc.

  • $5.63 Billion
  • Q3 2024

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Aug 06, 2024
BUY
$0.03 - $0.04 $15 - $20
515 New
515 $0

Others Institutions Holding CVSI

# of Institutions
2
Shares Held
5.1K
Call Options Held
0
Put Options Held
0
View Full List

About CV Sciences, Inc.

CVSI Quotes by TradingView
  • Ticker CVSI
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 147,794,000
  • Market Cap $5.91M
  • Description
  • CV Sciences, Inc. operates as a life science company in North America. It operates in two segments, Consumer Products and Specialty Pharmaceutical. The Consumer Products segment develops, manufactures, and markets plant-based dietary supplements and hemp-based cannabidiol (CBD) products under the PlusCBD, ProCBD, HappyLane, CV Acute, CV Defense,...
More about CVSI
Track This Portfolio

Track Hantz Financial Services, Inc. Portfolio

Follow Hantz Financial Services, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hantz Financial Services, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Hantz Financial Services, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email